UAE Allergy Treatment Market Overview, 2030

The market for allergy treatment in the UAE is experiencing significant expansion, driven by accelerating urbanization, with inhabitants moving to densely populated cities where issues like poor air quality, dust from construction, vehicle emissions, and indoor allergens are more common. This urban migration leads to increased exposure to environmental triggers, such as pollen from urban greenery, mold spores in damp interiors, and particulate matter from industrial areas. At the same time, lifestyle changes which include a higher intake of processed foods, extended time spent in climate-controlled spaces, and less outdoor exercise have led to rising rates and earlier occurrences of allergic diseases like rhinitis, asthma, dermatitis, and food allergies. Consequently, the pharmaceutical sector, which includes antihistamines, corticosteroids, leukotriene inhibitors, and combination treatments, remains a key pathway for treatment, supported by the UAE’s established retail pharmacy systems and hospital prescription services. Growing health awareness, along with compulsory health insurance in important emirates, is enhancing diagnosis rates and increasing treatment acceptance. Allergen-specific immunotherapy is also developing, primarily in urban areas such as Dubai and Abu Dhabi, where allergists and diagnostic laboratories are grouped together. Although distribution is largely led by retail and hospital pharmacies, digital health platforms and telehealth consultations are beginning to offer new possibilities for remote prescription refills and monitoring of patients. Global pharmaceutical firms are broadening their reach through collaborations with local distributors, while domestic companies are creating tailored formulations that target specific regional allergens like date palm pollen and desert dust. Public health initiatives supported by the government and educational programs in schools are steadily improving early detection rates, particularly among children.

According to the research report, ""UAE Allergy Treatment Market Overview, 2030,"" published by Bonafide Research, the UAE Allergy Treatment market is anticipated to grow at more than 6.92% CAGR from 2025 to 2030. The allergy treatment market in the UAE is experiencing significant, ongoing growth due to concerted initiatives aimed at broadening healthcare access and diversifying treatment options. A notable investment from the public sector in medical facilities, along with private funding, has led to an increase in the number of specialized allergy laboratories, clinics, and advanced diagnostic and therapeutic services in major cities such as Abu Dhabi, Dubai, and Sharjah. The requirement for health insurance in most emirates has lowered out-of-pocket expenses, allowing more patients to access both standard drug therapies such as antihistamines, corticosteroids, and leukotriene receptor antagonists and innovative treatments like allergen-specific immunotherapy AIT. Retail pharmacy networks serve as the main distribution sources for both over-the-counter and prescription drugs, whereas hospital pharmacies and specialized centers focus on more complex or serious cases, guaranteeing the availability of high-quality treatments within integrated healthcare environments. Government initiatives in e-health and telemedicine are also enhancing remote access to prescriptions, follow-up appointments, and patient education, which is especially advantageous for those in remote or less served regions. In terms to these structural enhancements, there’s increasing attention on customized treatment plans that tackle local triggers like dust mites, desert dust, mold, and pollen from date palms. Global pharmaceutical companies are boosting their connections through local partners, introducing new formulations and delivery systems to the market, while domestic businesses are creating innovative solutions relevant to local needs. Public awareness initiatives often conducted in partnership with schools, community groups, and media are enhancing knowledge about prevention, early detection, and long-term management strategies.

The allergy treatment market in the UAE by type is divided into Eye Allergy, Skin Allergy, Food Allergy and Other Allergies is largely influenced by the high rates of skin and respiratory allergic conditions, which are responsible for most diagnoses and healthcare appointments in this area. Skin allergies including atopic dermatitis, urticaria, and contact dermatitis are caused by environmental irritants, extended exposure to air conditioning, and elevated humidity that worsen eczema outbreaks. Respiratory allergies, particularly allergic rhinitis and asthma, are triggered by specific regional factors like desert dust, sandstorms, pollen from date palms, and mold spores prevalent in humid coastal areas. This leads to significant demand for antihistamines, corticosteroid creams, receptor antagonist sprays, leukotrienes, and bronchodilators, available through retail and hospital pharmacies. Recently, there has been increasing awareness of food allergies notably to peanuts, tree nuts, shellfish, dairy, and eggs due to improved diagnostic methods, heightened public knowledge, and active screening in children's health and school programs. The growing number of expatriates has brought a more diverse diet, leading to greater exposure to new allergens, while trends towards processed and convenience foods have raised risks. The healthcare system is adapting by making epinephrine auto-injectors more accessible, offering dietary guidance, and providing specialized allergist services in key emirates. Public health initiatives, often in partnership with schools and community groups, aim to educate parents, teachers, and food service employees on preventing and managing severe allergic reactions. This expanded awareness of allergies is leading to a gradual shift in the market from only treating symptoms to a more holistic approach, which includes preventive care, personalized patient education, and disease-modifying treatments like allergen-specific immunotherapy in urban areas.

In allergy treatment in the UAE, by treatment type is divided into Anti-Allergy Drugs and Immunotherapy the medication remains the key sector, serving as the foundation for managing symptoms related to skin, respiratory, and newly emerging food allergies. This segment encompasses various readily accessible options like over-the-counter antihistamines, intranasal and topical corticosteroids, decongestants, leukotriene receptor antagonists, and bronchodilators, which can be found across the nation’s broad retail landscape and are frequently prescribed by pharmacy networks in hospitals. Their prevalent use is bolstered by specialist clinics that provide quick symptom relief, relatively low prices, familiarity among prescribers, and strong insurance support, making them the preferred choice for the majority of patients. These products are employed for both seasonal issues, such as pollen-induced rhinitis, and ongoing ailments like asthma and eczema, with branded and generic selections ensuring reach across various income levels. Simultaneously, allergen-specific immunotherapy AIT, administered through subcutaneous injections SCIT or sublingual tablets/drops SLIT, represents a smaller but progressively developing sector, particularly in urban centers like Dubai, Abu Dhabi, and Sharjah. Growing recognition of AIT's potential to modify diseases is becoming more common among specialists and informed patients, stimulated by focused public health initiatives, ongoing medical training programs, and workshops led by experts. However, the adoption of AIT is still influenced by aspects such as higher initial costs, prolonged treatment durations, and restricted availability of specialists outside major urban diagnostic hubs. Nevertheless, enhanced infrastructure, wider insurance coverage for specific procedures, and increasing private investment in allergy clinics are improving access. Urban residents dealing with severe allergic reactions that do not improve with typical medications are starting to seek out long-term solutions like immunotherapy.

UAE's allergy treatment by distribution channel is divided into Hospital Pharmacies, Retail Pharmacies, Online Retailers and Others. Pharmacies connected to hospitals are crucial in providing medications that require prescriptions, advanced treatments, and specialized therapies like allergen-targeted immunotherapy. Located within hospitals and specialized medical facilities, these pharmacies ensure a smooth connection between diagnosis, prescription, and medication dispensing, especially for urgent situations, complicated treatment plans, and therapies needing close clinical observation. Their robust relationships with insurance providers and streamlined purchasing methods assure reliable access to high-quality products, making them essential for patients in need of thorough allergy treatment. Community pharmacies represent another important channel, providing extensive coverage across different areas, easy access for walk-in customers, and a wide assortment of over-the-counter OTC products, including antihistamines, creams, corticosteroid sprays, and bronchodilator medications. Their contribution to managing long-term health issues is supported by guidance from pharmacists, services for refills, and competitive prices for both brand-name and generic options, meeting various income needs. Lately, online services have surfaced as a rapidly expanding sector, utilizing the rise of e-commerce, better digital payment systems, and changing regulations that allow licensed e-pharmacy operations. These platforms are becoming popular in urban areas, offering delivery services, subscription refills, and confidential purchasing choices features particularly appreciated by tech-savvy shoppers, busy professionals, and patients dealing with ongoing health issues, albeit with prescription requirements. However, growth can be limited by regulations, the need for cold storage logistics for some products, and inconsistent delivery reliability outside of large cities. Collaborative ventures between major retail chains and digital health companies are enhancing market presence by integrating physical stores with online accessibility.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Allergy Care Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Type
• Eye Allergy
• Skin Allergy
• Food Allergy
• Other Allergies

By Treatment Type
• Anti-Allergy Drugs
• Immunotherapy

By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Retailers
• Others Show more